参考文献/References:
[1] Haugen BR,Alexander EK,Bible KC,et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].Thyroid,2016,26(1):1-133.DOI:10.1089/thy.2015.0020.
[2] Li Y,Teng D,Ba J,et al.Efficacy and safety of long-term universal salt iodization on thyroid disorders:epidemiological evidence from 31 Provinces of mainland China[J].Thyroid,2020,30(4):568-579.DOI:10.1089/thy.2019.0067.
[3] Miranda-Filho A,Lortet-Tieulent J,Bray F,et al.Thyroid cancer incidence trends by histology in 25 countries:a population-based study[J].Lancet Diabetes Endocrinol,2021,9(4):225-234.DOI:10.1016/S2213-8587(21)00027-9.
[4] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
[5] Ahn HS,Kim HJ,Welch HG.Korea's thyroid-cancer "epidemic"--screening and overdiagnosis[J].N Engl J Med,2014,371(19):1765-1767.DOI:10.1056/NEJMp1409841.
[6] Zevallos JP,Hartman CM,Kramer JR,et al.Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration:a study of the Veterans Affairs health care system[J].Cancer,2015,121(5):741-746.DOI:10.1002/cncr.29122.
[7] McLeod DSA,Zhang L,Durante C,et al.Contemporary debates in adult papillary thyroid cancer management[J].Endocr Rev,2019,40(6):1481-1499.DOI:10.1210/er.2019-00085.
[8] Tessler FN,Middleton WD,Grant EG,et al.ACR thyroid imaging,reporting and data system(TI-RADS):white paper of the ACR TI-RADS committee[J].J Am Coll Radiol,2017,14(5):587-595.DOI:10.1016/j.jacr.2017.01.046.
[9] 中华医学会超声医学分会浅表器官和血管学组,中国甲状腺与乳腺超声人工智能联盟.2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS[J].中华超声影像学杂志,2021,30(3):185-200.DOI:10.3760/cma.j.cn131148-20210205-00092.
[10] Hamour AF,Yang W,Lee JJW,et al.Association of the implementation of a standardized thyroid ultrasonography reporting program with documentation of nodule characteristics[J].JAMA Otolaryngol Head Neck Surg,2021,147(4):343-349.DOI:10.1001/jamaoto.2020.5233.
[11] Ghazizadeh S,Kelly TL,Khajanchee YS,et al.Standardization of thyroid ultrasound reporting in the community setting decreases biopsy rates[J].Clin Endocrinol(Oxf),2021,94(6):1035-1042.DOI:10.1111/cen.14431.
[12] 季沁,徐书杭,王建华,等.甲状腺结节超声诊断报告系统的研究进展[J].国际内分泌代谢杂志,2018,38(6):381-385.DOI:10.3760/cma.j.issn.1673-4157.2018.06.005.
[13] Dahabreh IJ,Chung M,Balk EM,et al.Active surveillance in men with localized prostate cancer:a systematic review[J].Ann Intern Med,2012,156(8):582-590.DOI:10.7326/0003-4819-156-8-201204170-00397.
[14] Miyauchi A,Ito Y,Oda H.Insights into the management of papillary microcarcinoma of the thyroid[J].Thyroid,2018,28(1):23-31.DOI:10.1089/thy.2017.0227.
[15] Rozenbaum A,Buffet C,Bigorgne C,et al.Outcomes of active surveillance of EU-TIRADS 5 thyroid nodules[J].Eur J Endocrinol,2021,184(5):677-686.DOI:10.1530/EJE-20-1481.
[16] 中国抗癌协会甲状腺癌专业委员会(CATO).甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床,2016,43(10):405-411.DOI:10.3969/j.issn.1000-8179.2016.10.001.
[17] Laurberg P,Bülow Pedersen I,Knudsen N,et al.Environmental iodine intake affects the type of nonmalignant thyroid disease[J].Thyroid,2001,11(5):457-469.DOI:10.1089/105072501300176417.
[18] Carlé A,Krejbjerg A,Laurberg P.Epidemiology of nodular goitre.Influence of iodine intake[J].Best Pract Res Clin Endocrinol Metab,2014,28(4):465-479.DOI:10.1016/j.beem.2014.01.001.
[19] Grussendorf M,Reiners C,Paschke R,et al.Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination:a randomized,placebo-controlled trial[J].J Clin Endocrinol Metab,2011,96(9):2786-2795.DOI:10.1210/jc.2011-0356.
[20] Cléro É,Doyon F,Chungue V,et al.Dietary iodine and thyroid cancer risk in French Polynesia:a case-control study[J].Thyroid,2012,22(4):422-429.DOI:10.1089/thy.2011.0173.
[21] 中华医学会地方病学分会,中国营养学会,中华医学会内分泌学分会.中国居民补碘指南[EB/OL].2018.http://www.nhc.gov.cn/ewebeditor/uploadfile/2018/05/20180515144010634.pdf.
相似文献/References:
[1]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(06):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[2]张蓉,俞立波,李连喜.组蛋白修饰与甲状腺癌[J].国际内分泌代谢杂志,2014,(05):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
Zhang Rong,Yu Libo,Li Lianxi..Histone modification and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2014,(06):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(06):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]李兴佳,徐书杭,刘超.雌激素及其受体与甲状腺癌的关系[J].国际内分泌代谢杂志,2016,36(04):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
Li Xingjia,Xu Shuhang,Liu Chao.Relationship between estrogen, its receptors and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2016,36(06):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
[5]郑仁东,刘超.白细胞介素-6与甲状腺疾病[J].国际内分泌代谢杂志,2016,36(05):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
Zheng Rendong,Liu Chao.Interleukin-6 and thyroid disease[J].International Journal of Endocrinology and Metabolism,2016,36(06):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
[6]郑仁东,刘超.STAT3与甲状腺肿瘤[J].国际内分泌代谢杂志,2017,37(05):345.
Zheng Rendong,Liu Chao..STAT3 and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2017,37(06):345.
[7]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节
与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[8]孟祥慧 徐书杭 陈国芳 刘超.二甲双胍在甲状腺癌防治中的作用[J].国际内分泌代谢杂志,2018,38(04):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
Meng Xianghui*,Xu Shuhang,Chen Guofang,et al.Role of metformin in prevention and treatment of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2018,38(06):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
[9]曹星月 武晓泓.基因拷贝数异常在甲状腺癌诊断和预后判断中的
应用进展[J].国际内分泌代谢杂志,2019,39(01):29.[doi:10.3760/cma.j.issn.1673-4157.2019.01.007]
Cao Xingyue,Wu Xiaohong.Progress in the application of gene copy number variations in diagnosis and prognosis of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2019,39(06):29.[doi:10.3760/cma.j.issn.1673-4157.2019.01.007]
[10]张会峰 胡天赤 陈学勤 叶向荣 刘超.丙型肝炎病毒感染与自身免疫性甲状腺疾病
及甲状腺癌风险[J].国际内分泌代谢杂志,2019,39(02):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
Zhang Huifeng,Hu Tianchi,Chen Xueqin,et al.Relationship between hepatitis C virus infection and the risk of autoimmune thyroid diseases and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2019,39(06):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
[11]张雅,相萍萍,徐书杭,等.经皮无水乙醇注射治疗甲状腺结节:老方法的新认识[J].国际内分泌代谢杂志,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
Zhang Ya,Xiang Pingping,Xu Shuhang,et al.Percutaneous ethanol ablation for thyroid nodules: new perspectives on an old paradigm[J].International Journal of Endocrinology and Metabolism,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]